Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.

Nakata S, Imagawa A, Miyata Y, Yoshikawa A, Kozawa J, Okita K, Funahashi T, Nakamura S, Matsubara K, Iwahashi H, Shimomura I.

Immunol Lett. 2013 Nov-Dec;156(1-2):149-55. doi: 10.1016/j.imlet.2013.10.004. Epub 2013 Oct 25.

PMID:
24177169
2.

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.

Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaëlsson J.

Blood. 2010 Feb 11;115(6):1166-74. doi: 10.1182/blood-2009-09-245746. Epub 2009 Nov 10.

3.
4.

Expression of NK cell receptors on decidual T cells in human pregnancy.

Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH.

J Reprod Immunol. 2009 Jun;80(1-2):22-32. doi: 10.1016/j.jri.2009.02.004. Epub 2009 Apr 25.

PMID:
19394706
5.

Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.

Son SW, Kim EO, Ryu ES, Kim TJ, Kim JN, Choi JE, Kye YC, Lee KM.

Br J Dermatol. 2009 Aug;161(2):281-8. doi: 10.1111/j.1365-2133.2009.09178.x. Epub 2009 Apr 29.

PMID:
19438461
6.

CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Morel E, Escamochero S, Cabañas R, Díaz R, Fiandor A, Bellón T.

J Allergy Clin Immunol. 2010 Mar;125(3):703-10, 710.e1-710.e8. doi: 10.1016/j.jaci.2009.10.030. Epub 2010 Feb 4.

PMID:
20132973
8.

High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.

Wang Y, Xu H, Zheng X, Wei H, Sun R, Tian Z.

Cell Mol Immunol. 2007 Oct;4(5):377-82.

9.

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.

Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L.

Eur J Immunol. 1997 Jun;27(6):1374-80.

PMID:
9209487
10.

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.

Walsh CE, Ryan EJ, O'Farrelly C, Golden-Mason L, FitzGerald O, Veale DJ, Bresnihan B, Fearon U.

PLoS One. 2011;6(11):e27182. doi: 10.1371/journal.pone.0027182. Epub 2011 Nov 15.

11.

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Nielsen N, Pascal V, Fasth AE, Sundström Y, Galsgaard ED, Ahern D, Andersen M, Baslund B, Bartels EM, Bliddal H, Feldmann M, Malmström V, Berg L, Spee P, Söderström K.

Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271.

12.

Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.

Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.

Fertil Steril. 2008 May;89(5 Suppl):1490-6. Epub 2007 Aug 13.

PMID:
17706207
13.

Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells.

Enqvist M, Nilsonne G, Hammarfjord O, Wallin RP, Björkström NK, Björnstedt M, Hjerpe A, Ljunggren HG, Dobra K, Malmberg KJ, Carlsten M.

J Immunol. 2011 Oct 1;187(7):3546-54. doi: 10.4049/jimmunol.1100610. Epub 2011 Sep 2.

14.

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.

J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.

15.

Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.

Sugita J, Tanaka J, Yasumoto A, Shiratori S, Wakasa K, Kikuchi M, Shigematsu A, Kondo T, Asaka M, Imamura M.

Ann Hematol. 2010 Feb;89(2):115-20. doi: 10.1007/s00277-009-0780-0. Epub 2009 Jul 4.

PMID:
19578849
16.

CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma.

Lin CW, Chen YH, Chuang YC, Liu TY, Hsu SM.

Blood. 2003 Oct 1;102(7):2623-31. Epub 2003 Jun 19.

17.

Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.

Saether PC, Hoelsbrekken SE, Fossum S, Dissen E.

J Immunol. 2011 Dec 15;187(12):6365-73. doi: 10.4049/jimmunol.1102345. Epub 2011 Nov 14.

18.
19.

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.

Nature. 1998 Feb 19;391(6669):795-9.

PMID:
9486650
20.

[Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].

Nong L, Zhang S, Li Y, Zhang Y, Wang Y, Li T.

Zhonghua Bing Li Xue Za Zhi. 2010 May;39(5):319-24. Chinese.

PMID:
20654155

Supplemental Content

Support Center